InsiderClue
Stocks · Health care · Pharmaceutical Preparations

EXICURE, INC.

XCUR Clue Score25
United States Fiscal year ends December CIK 0001698530
$1.05 +5.00% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.05 −13.93% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 22 May 2018. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue1.0Operating income−16.2Net income−16.9Fiscal year 2017Revenue9.7 +838.1%Operating income−10.4Net income−11.0Fiscal year 2018Revenue0.1 −98.8%Operating income−21.8Net income−22.4Fiscal year 2019Revenue1.3 +998.3%Operating income−26.6Net income−26.3Fiscal year 2020Revenue16.6 +1,181.9%Operating income−25.4Net income−24.7EPS, diluted−0.28Fiscal year 2021Revenue−0.5 −102.9%Operating income−62.5Net income−64.1EPS, diluted−21.70Fiscal year 2022Revenue28.8Operating income−1.8Net income−2.6EPS, diluted−0.56Fiscal year 2023Revenue0.0 −100.0%Operating income−15.0Net income−16.9EPS, diluted−10.55Fiscal year 2024Revenue0.5Operating income−12.2Net income−9.7EPS, diluted−4.75Fiscal year 2025Revenue0.0 −100.0%Operating income−4.2Net income−4.9EPS, diluted−0.79
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 1.0 9.7 0.1 1.3 16.6 −0.5 28.8 0.0 0.5 0.0
Growth +838.1% −98.8% +998.3% +1,181.9% −102.9% −100.0% −100.0%
Operating income −16.2 −10.4 −21.8 −26.6 −25.4 −62.5 −1.8 −15.0 −12.2 −4.2
Net income −16.9 −11.0 −22.4 −26.3 −24.7 −64.1 −2.6 −16.9 −9.7 −4.9
Growth
EPS, diluted n/a n/a n/a n/a −0.28 −21.70 −0.56 −10.55 −4.75 −0.79

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−1,560.0%Net margin−1,635.2%Free cash flow margin−525.5%Fiscal year 2017Operating margin−107.1%Net margin−113.3%Free cash flow margin−213.1%Fiscal year 2018Operating margin−18,490.7%Net margin−18,994.1%Free cash flow margin−16,594.1%Fiscal year 2019Operating margin−2,053.8%Net margin−2,029.6%Free cash flow margin18.1%Fiscal year 2020Operating margin−153.1%Net margin−148.5%Free cash flow margin−255.5%Fiscal year 2021Operating margin12,950.1%Net margin13,271.6%Free cash flow margin7,409.3%Fiscal year 2022Operating margin−6.4%Net margin−9.0%Free cash flow margin−123.7%Fiscal year 2023Fiscal year 2024Operating margin−2,446.4%Net margin−1,940.2%Free cash flow margin−582.0%Fiscal year 2025
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −1,560.0% −107.1% −18,490.7% −2,053.8% −153.1% 12,950.1% −6.4% n/a −2,446.4% n/a
Net margin −1,635.2% −113.3% −18,994.1% −2,029.6% −148.5% 13,271.6% −9.0% n/a −1,940.2% n/a
Free cash flow margin −525.5% −213.1% −16,594.1% 18.1% −255.5% 7,409.3% −123.7% n/a −582.0% n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−5.1Capital expenditure−0.4Free cash flow−5.4Fiscal year 2017Operating cash flow−19.8Capital expenditure−0.9Free cash flow−20.7Fiscal year 2018Operating cash flow−19.5Capital expenditure−0.1Free cash flow−19.6Fiscal year 2019Operating cash flow1.3Capital expenditure−1.1Free cash flow0.2Fiscal year 2020Operating cash flow−39.3Capital expenditure−3.2Free cash flow−42.4 −18,160.0%Fiscal year 2021Operating cash flow−34.8Capital expenditure−1.0Free cash flow−35.8Fiscal year 2022Operating cash flow−35.7Capital expenditure−0.0Free cash flow−35.7Fiscal year 2023Operating cash flow−10.4Capital expenditure0.0Free cash flow−10.4Fiscal year 2024Operating cash flow−2.9Capital expenditure0.0Free cash flow−2.9Fiscal year 2025Operating cash flow−8.6Capital expenditure−0.0Free cash flow−8.6
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −5.1 −19.8 −19.5 1.3 −39.3 −34.8 −35.7 −10.4 −2.9 −8.6
Capital expenditure −0.4 −0.9 −0.1 −1.1 −3.2 −1.0 −0.0 0.0 0.0 −0.0
Free cash flow −5.4 −20.7 −19.6 0.2 −42.4 −35.8 −35.7 −10.4 −2.9 −8.6
Growth −18,160.0%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash19.6Total debt5.7Net cash (debt)14.0Shareholders’ equity2.4Debt to equity2.31Fiscal year 2017Cash25.8Total debt4.9Net cash (debt)20.9Shareholders’ equity20.0Debt to equity0.24Fiscal year 2018Cash26.3Total debt4.9Net cash (debt)21.3Shareholders’ equity21.0Debt to equity0.24Fiscal year 2019Cash48.5Total debt5.0Net cash (debt)43.5Shareholders’ equity80.7Debt to equity0.06Fiscal year 2020Cash33.3Total debt16.6Net cash (debt)16.7Shareholders’ equity61.5Debt to equity0.27Fiscal year 2021Cash34.6Total debt6.9Net cash (debt)27.8Shareholders’ equity11.2Debt to equity0.61Fiscal year 2022Cash8.6Total debt0.0Net cash (debt)8.6Shareholders’ equity14.9Debt to equity0.00Fiscal year 2023Cash0.8Total debt0.0Net cash (debt)0.8Shareholders’ equity3.0Debt to equity0.00Fiscal year 2024Cash12.5Shareholders’ equity6.8Fiscal year 2025Cash3.7Shareholders’ equity3.9
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 19.6 25.8 26.3 48.5 33.3 34.6 8.6 0.8 12.5 3.7
Total debt 5.7 4.9 4.9 5.0 16.6 6.9 0.0 0.0 n/a n/a
Net cash (debt) 14.0 20.9 21.3 43.5 16.7 27.8 8.6 0.8 n/a n/a
Shareholders’ equity 2.4 20.0 21.0 80.7 61.5 11.2 14.9 3.0 6.8 3.9
Debt to equity 2.31 0.24 0.24 0.06 0.27 0.61 0.00 0.00 n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021† 31 Dec 2021 FY2022† 31 Dec 2022 FY2023† 31 Dec 2023 FY2024 31 Dec 2024 FY2025† 31 Dec 2025
Revenue and profit
1.0 9.7 0.1 1.3 16.6 −0.5 28.8 0.0 0.5 0.0
Growth +838.1% −98.8% +998.3% +1,181.9% −102.9% −100.0% −100.0%
13.7 13.1 14.1 19.3 32.1 49.0 19.8 1.4 0.0 3.3
3.5 7.0 7.8 8.6 10.0 13.1 10.9 11.7 5.4 6.8
−16.2 −10.4 −21.8 −26.6 −25.4 −62.5 −1.8 −15.0 −12.2 −4.2
Growth
−16.9 −12.0 n/a −26.3 −24.7 −64.1 −2.4 −16.9 −9.7 −5.6
0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 −0.6
−16.9 −11.0 −22.4 −26.3 −24.7 −64.1 −2.6 −16.9 −9.7 −4.9
Growth
Per share
n/a n/a n/a n/a −0.28 −21.70 −0.56 −10.55 −4.75 −0.79
n/a n/a n/a n/a −0.28 −21.70 −0.56 −10.55 −4.75 −0.79
Growth
n/a n/a n/a n/a 87.2 3.0 4.6 1.6 2.0 6.3
n/a n/a n/a n/a 87.2 3.0 4.6 1.6 2.0 6.3
Growth −96.6% +56.4% −65.3% +27.5% +208.2%

† The diluted share count jumps at 2021 and 2022 and 2023 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 10 of 10 years on file.